NO147: A Randomized Phase III Trial of Oxaliplatin Plus 5-Fluorouracil, and Leucovorin (Modified FOLFOX6) with or without Cetuximab after Curative Resection for Patients with Stage III Colon Cancer

"NO147: A Randomized Phase III Trial of Oxaliplatin Plus 5-Fluorouracil, and Leucovorin (Modified FOLFOX6) with or without Cetuximab after Curative Resection for Patients with Stage III Colon Cancer." Oncology Issues, 23(2), pp. 20–21

Additional information

Notes on contributors

Steven R. Alberts

Steven R. Alberts, MD, is the co-chair for the GI Committee with the North Central Cancer Treatment Group (NCCTG), Mayo Clinic College of Medicine, and the Mayo Clinic, Division of Medical Oncology in Rochester, Minn. Frank Sinicrope, MD, is the Translational Research Chair for the GI Committee with the North Central Cancer Treatment Group, Mayo Clinic College of Medicine.

Frank Sinicrope

Steven R. Alberts, MD, is the co-chair for the GI Committee with the North Central Cancer Treatment Group (NCCTG), Mayo Clinic College of Medicine, and the Mayo Clinic, Division of Medical Oncology in Rochester, Minn. Frank Sinicrope, MD, is the Translational Research Chair for the GI Committee with the North Central Cancer Treatment Group, Mayo Clinic College of Medicine.